Impression 2D-3D dans les pharmacies hospitalieres: quels roles et quels challenges? - Archive ouverte HAL Access content directly
Journal Articles Annales Pharmaceutiques Françaises Year : 2021

Impression 2D-3D dans les pharmacies hospitalieres: quels roles et quels challenges?

(1) , (1) , (1) , (1) , (1) , (2)
1
2

Abstract

The additive technology or 2D and 3D printing are increasingly used in various industrial fields, from aeronautics to mechanics but also in the fields of health such as dentistry or for bone reconstructions. These techniques have been studied for about fifteen years by the academic community in the pharmaceutical field (medical device and drug), and recently they have started to be applied to produce drugs in industry and in hospitals. Indeed, the Food and Drug Administration approved in August 2015 the marketing of the first drug printed by additive technique, then in 2018 the first clinical trial using 3D printed drugs was carried out in Great Britain by a hospital pharmacy. 2D-3D printing is presented as one of the tools of a more personalized medicine, the techniques of additive printing allowing the production of tabs containing several drugs in one tab (polypills) and the development of custom modified-releases drugs. This approach could allow better acceptance of the finished product and secure manufacturing. The objective of this work is to highlight relevant printing technologies for implementation in hospital pharmacies, and to see how these technologies could lead to a change in pharmaceutical practices, to improve patient care.

Dates and versions

hal-03290545 , version 1 (19-07-2021)

Identifiers

Cite

M Annereau, B Toussaint, A Dufay Wojcicki, S Dufay, R Diaz Salmeron, et al.. Impression 2D-3D dans les pharmacies hospitalieres: quels roles et quels challenges?. Annales Pharmaceutiques Françaises, 2021, 79 (4), pp.361-374. ⟨10.1016/j.pharma.2021.01.002⟩. ⟨hal-03290545⟩
26 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More